Abstract
A passive hemagglutination (PHA) test for measles was evaluated in comparison with hemagglutination inhibition (HI) and neutralization (NT) tests. The PHA test determines exclusively the level of antibody directed to the hemagglutinin protein of measles virus. The ratio of PHA to HI titer was 1 to 32 (geometric mean, 6.5) for the first 5 weeks of infection but declined to near unity thereafter. It gradually increased again to 4 to 32 (geometric mean, 11.7) over several years. The initial high PHA titer relative to the HI titer was most likely due to the presence of the immunoglobulin M antibody known to be efficient in agglutination, because 2-mercaptoethanol (2ME) treatment of sera reduced the PHA titer to a level similar to that of the HI titer. The PHA titer in sera obtained after the convalescent phase was insensitive to 2ME, and the relative increase in the PHA over the HI titer was presumably a result of increased antibody avidity. In some individuals, the HI titer fell to below detectable levels several years after either natural infection or vaccination, but the PHA as well as the NT titer remained positive. The PHA titer was therefore a more reliable and more sensitive indicator of immune status against measles than the HI titer. The decrease in PHA titer by 2ME treatment provided evidence of a current or very recent infection. PHA was found to be useful both for assessing immunity status and for serodiagnosis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Choppin P. W., Scheid A. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis. 1980 Jan-Feb;2(1):40–61. doi: 10.1093/clinids/2.1.40. [DOI] [PubMed] [Google Scholar]
- Cremer N. E., Cossen C. K., Shell G., Diggs J., Gallo D., Schmidt N. J. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. J Clin Microbiol. 1985 Jun;21(6):869–874. doi: 10.1128/jcm.21.6.869-874.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EISEN H. N., SISKIND G. W. VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE. Biochemistry. 1964 Jul;3:996–1008. doi: 10.1021/bi00895a027. [DOI] [PubMed] [Google Scholar]
- Fukuda A., Sugiura A. Temperature-dependent growth restriction in measles vaccine strains. Jpn J Med Sci Biol. 1983 Dec;36(6):331–335. doi: 10.7883/yoken1952.36.331. [DOI] [PubMed] [Google Scholar]
- Ghyka G. R., Cernescu C., Cajal N. Studies on the sensitivity of a passive hemagglutination test in the detection of antimeasles antibodies. Rev Roum Virol. 1973;10(4):295–300. [PubMed] [Google Scholar]
- Inouye S., Hasegawa A., Matsuno S., Katow S. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol. 1984 Sep;20(3):525–529. doi: 10.1128/jcm.20.3.525-529.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Inouye S., Satoh K., Tajima T. Single-serum diagnosis of rubella by combined use of the hemagglutination inhibition and passive hemagglutination tests. J Clin Microbiol. 1986 Feb;23(2):388–391. doi: 10.1128/jcm.23.2.388-391.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krugman S. Further-attenuated measles vaccine: characteristics and use. Rev Infect Dis. 1983 May-Jun;5(3):477–481. doi: 10.1093/clinids/5.3.477. [DOI] [PubMed] [Google Scholar]
- Neumann P. W., Weber J. M., Jessamine A. G., O'Shaughnessy M. V. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol. 1985 Aug;22(2):296–298. doi: 10.1128/jcm.22.2.296-298.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norrby E., Gollmar Y. Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun. 1975 Feb;11(2):231–239. doi: 10.1128/iai.11.2.231-239.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norrby E., Orvell C., Vandvik B., Cherry J. D. Antibodies against measles virus polypeptides in different disease conditions. Infect Immun. 1981 Dec;34(3):718–724. doi: 10.1128/iai.34.3.718-724.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orenstein W. A., Albrecht P., Herrmann K. L., Bernier R., Bart K. J., Rovira E. Z. The plaque-neutralization test as a measure of prior exposure to measles virus. J Infect Dis. 1987 Jan;155(1):146–149. doi: 10.1093/infdis/155.1.146. [DOI] [PubMed] [Google Scholar]
- Pedersen I. R., Mordhorst C. H., Ewald T., von Magnus H. Long-term antibody response after measles vaccination in an isolated arctic society in Greenland. Vaccine. 1986 Sep;4(3):173–178. doi: 10.1016/0264-410x(86)90006-x. [DOI] [PubMed] [Google Scholar]
- Sato T. A., Fukuda A., Sugiura A. Characterization of major structural proteins of measles virus with monoclonal antibodies. J Gen Virol. 1985 Jul;66(Pt 7):1397–1409. doi: 10.1099/0022-1317-66-7-1397. [DOI] [PubMed] [Google Scholar]
- Steward M. W., Lew A. M. The importance of antibody affinity in the performance of immunoassays for antibody. J Immunol Methods. 1985 Apr 22;78(2):173–190. doi: 10.1016/0022-1759(85)90074-2. [DOI] [PubMed] [Google Scholar]
- Weigle K. A., Murphy M. D., Brunell P. A. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol. 1984 Mar;19(3):376–379. doi: 10.1128/jcm.19.3.376-379.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]